Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/184347
Title: | Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis |
Author: | Castañeda, Ximena García de la Mària, Cristina Gasch, Oriol Pericàs, Juan M. Soy Muner, Dolors Cañas Pacheco, Maria Alejandra Falces Salvador, Carles García González, Javier Hernández-Meneses, Marta Vidal, Bàrbara Almela, Manel Quintana, Eduard Tolosana, José M. (José María) Fuster, David Llopis, Jaume Dahl, Anders Moreno, Asuncion Marco, Francesc Miró Meda, José M. Hospital Clínic Endocarditis Study Group |
Keywords: | Endocarditis Staphylococcus aureus Medicaments antibacterians Epidemiologia Endocarditis Staphylococcus aureus Antibacterial agents Epidemiology |
Issue Date: | 12-May-2021 |
Publisher: | Oxford University Press |
Abstract: | Objectives: To investigate if the addition of cloxacillin to vancomycin enhances the activity of both monotherapies for treating MSSA and MRSA experimental endocarditis (EE) in rabbits. Methods: Vancomycin plus cloxacillin was compared with the respective monotherapies and daptomycin. In vitro time-kill studies were performed using standard (105 cfu) and high (108 cfu) inocula of five MRSA, one glycopeptide-intermediate (GISA) and five MSSA strains. One MSSA (MSSA-678) and one MRSA (MRSA-277) strain were selected to be used in the in vivo model. A human-like pharmacokinetics model was applied and the equivalents of cloxacillin 2 g/4 h IV and daptomycin 6 mg/kg/day IV were administered. To optimize vancomycin activity, dosage was adjusted to achieve an AUC/MIC ≥400. Results: Daptomycin sterilized significantly more vegetations than cloxacillin (13/13, 100% versus 9/15, 60%; P = 0.02) and showed a trend of better activity than vancomycin (10/14, 71%; P = 0.09) and vancomycin plus cloxacillin (10/14, 71%; P = 0.09) against MSSA-678. Addition of cloxacillin to vancomycin (13/15, 87%) was significantly more effective than vancomycin (8/16, 50%; P = 0.05) and showed similar activity to daptomycin (13/18, 72%; P = 0.6) against MRSA-277. In all treatment arms, the bacterial isolates recovered from vegetations were re-tested and showed the same daptomycin susceptibility as the original strains. Conclusions: Vancomycin plus cloxacillin proved synergistic and bactericidal activity against MRSA. Daptomycin was the most efficacious option against MSSA and similar to vancomycin plus cloxacillin against MRSA. In settings with high MRSA prevalence, vancomycin plus cloxacillin might be a good alternative for empirical therapy of S. aureus IE. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1093/jac/dkab069 |
It is part of: | Journal of Antimicrobial Chemotherapy, 2021, vol. 76, num. 6, p. 1539-1546 |
URI: | http://hdl.handle.net/2445/184347 |
Related resource: | https://doi.org/10.1093/jac/dkab069 |
ISSN: | 0305-7453 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Genètica, Microbiologia i Estadística) Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
711662.pdf | 1.03 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.